Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview

References

• Holmdahl L, Risberg B, Beck DE, et al. Adhesions: pathogenesis and prevention — panel discussion and summary. Eur J Surg 1997;163\(Suppl. 577):56–62
   Google Scholar
• Liakakos T, Thomakos N, Fine PM, et al. Peritoneal adhesions: etiology, pathophysiology and clinical significance. Recent advances in prevention and management. Dig Surg 2000;18:260–73
   Google Scholar
• Lower AIVI, Hawthorn RJS, Ellis H, et al. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. Br J Obstet Gynaecol 2000;107:855–62
   Google Scholar
• Menzies D. Postoperative adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993;72:147–53
   Google Scholar
• Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal pelvic surgery: a retrospective cohort study. Lancet 1997; 353:1476–80
   Google Scholar
• Schwemmle K. Ursachen von Verwachsungen im Abdomen. Langenbecks Arch Chir 1990;(Suppl. II): 1017–21
   Google Scholar
• Banerjee R, Laufer MR. Reproductive disorders associated with pelvic pain. Semin Pediatr Surg 1998; 7:52–61
   PubMedGoogle Scholar
• Korell M. Aktuelle Adhäsionsprophylaxe in der operativen Gynäkologie. Gynakologe 2002;35: 1218–23
   Google Scholar
• Lundorff P, Hahlin M, Kallfelt B, et al. Adhesion formation after laparoscopic surgery in tubal preg-nancy: a randomized trial versus laparotomy. Fertil Steril 1991;55:911–15
   PubMed Web of Science ®Google Scholar
• Korell M, Scheidel P, Hepp H. An animal experimental model for adhesion reformation. J Invest Surg 1994;7:409–15
   Google Scholar
• Tulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myo-mectomy and second look laparoscopy. Obstet Gynecol 1993;82:213–15
   Google Scholar
• Drolette CM, Badawy SZ. Pathophysiology of pelvic adhesions. Modern trends in preventing infertility. J Reprod Med 1992;37:107–21
   Google Scholar
• Ray FN, Larsen JW, Stillman RJ, Jacobs RJ. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993;176:271–6
   PubMedGoogle Scholar
• Ray FN, Denton WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1–9
   PubMed Web of Science ®Google Scholar
• Thornton MH, Johns DB, Campeau JD, et al. Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open-label pilot study. Hum Reprod 1998;13: 1480–5
   Google Scholar
• El-Saeed M, Hassan M, Abvolmaady Z, et al. High incidence of pelvic adhesions detected by second-look laparoscopy after laparoscopic ovarian drilling. Middle East Fertil Soc J 2000;5:219–25
   Google Scholar
• Canis M, Botchorishvili R, Tamburro S, et al. Adhesion prevention in the surgical treatment of pelvic endometriosis. Gynaecol Endosc 2001;10:99–106
   Google Scholar
• Grow DR, Coddington CC, Hsiu J-G, et al. Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates. Fertil Steril 1996;66:140–7
   Google Scholar
• Energeli MH, Kuscu E, Zeyneloglu HB, et al. GnRH for adhesion formation after uterine serosal injury in an euestrogenic milieu.J Reprod Med 2000; 45:35–8
   PubMedGoogle Scholar
• Canbaz MA, Ostiin C, Kocak I, Yanik FF. The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models. EurJ Obstet Gynecol Reprod Biol 1999;82:219–22
   PubMed Web of Science ®Google Scholar
• Wright JA, Sharpe-Timms KL. Gonadotropin-releasing hormone agonist therapy reduces post-operative adhesion formation and reformation of the adhesiolysis in rat models for adhesion formation and endometriosis. Fertil Steril 1995;63:1094–100
   PubMedGoogle Scholar
• Sharpe-Timms KL, Zimmer RL, Jolliff WJ, et al. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metallproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril 1998;69:916–23
   Google Scholar
• Winkler U, Bühler K, Koslowski S, et al. Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects ofleuprorelin acetate depot on coagulatory and fibrinolytic activities. Clin Ther 1992; 14(Suppl. A) :114–20
   Google Scholar
• Sulaiman H, Dawson L, Laurent GJ, et al. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans 2002;30:126–31
   PubMed Web of Science ®Google Scholar
• Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor-fi isoforms TGF-,81, TGF-fi2 and TGF-fi3 in surgi-cally induced pelvic adhesions in the rat. Obstet Gynecol 1994;83:449–54
   PubMed Web of Science ®Google Scholar
• Murphy J, Ghahary A. Uterine insulin-like growth factor: I. Regulation of expression and its role in estrogen uterine proliferation. Endocrinol Rev 1990; 11:443–53
   Google Scholar
• Iwamoto I, Imada A. Effects of growth factors in proliferation of cultured mesothelial cells. Nippon Jinzo Gakkai Shi 1992;34:1201–8
   PubMedGoogle Scholar
• Meresman GF, Bilotas MA, Lombardi E, et al. Effect of GnRH analogues on apoptosis and release of interleukin-1fi and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 2003;18:1767–71
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Harada T, Hone S, et al. Tumor necrosis factor-a-induced interleukin-8 (IL-8) ex-pression in endometrotic stromal cells, probably through nuclear factor-KB activation: gonadotro-pin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 2003;88: 730–5
   PubMedGoogle Scholar
• Wiczyk HP, Grow DR, Adams LA, et al. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril 1998;69: 511–16
   PubMedGoogle Scholar
• Alleem FA, Predanic M. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography. Gynecol Endocrinol 1995; 9:253–8
   PubMedGoogle Scholar
• Di Zerega GS. Contemporary adhesion prevention. Fertil Steril 1994;61:219–35
   PubMed Web of Science ®Google Scholar
• Henzl MR, Corson SL, Moghissi K, et al. Admin-istration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988; 318:485–9
   PubMed Web of Science ®Google Scholar
• Kuhlmann M, Gartner A, Regidor PA, et al. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy. Gynecol Endocrinol 1997;11: 169–74
   PubMed Web of Science ®Google Scholar
• Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002; 78:757–62
   PubMed Web of Science ®Google Scholar
• Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J 2000; 113:442–5.
   Google Scholar